Report overview
Bioidentical hormones are artificial hormones that are chemically similar to those naturallyproduced by the human body. Because they are chemically similar to the hormones produced by the body, bioidentical hormones act as the body's own hormones with very few side effects.
This report aims to provide a comprehensive presentation of the global market for Compounded Bioidentical Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounded Bioidentical Hormone Therapy. This report contains market size and forecasts of Compounded Bioidentical Hormone Therapy in global, including the following market information:
Global Compounded Bioidentical Hormone Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Compounded Bioidentical Hormone Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Compounded Bioidentical Hormone Therapy companies in 2022 (%)
The global Compounded Bioidentical Hormone Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oestrogen Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Compounded Bioidentical Hormone Therapy include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Compounded Bioidentical Hormone Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Compounded Bioidentical Hormone Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Type, 2022 (%)
Oestrogen
Progesterone
Testosterone
Global Compounded Bioidentical Hormone Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Compounded Bioidentical Hormone Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Compounded Bioidentical Hormone Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Compounded Bioidentical Hormone Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Compounded Bioidentical Hormone Therapy revenues share in global market, 2022 (%)
Key companies Compounded Bioidentical Hormone Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Compounded Bioidentical Hormone Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Bio station
Noven Pharmaceuticals
Novartis AG
Pfizer
TherapeuticsMD
Bayer AG
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Compounded Bioidentical Hormone Therapy, market overview.
Chapter 2: Global Compounded Bioidentical Hormone Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Compounded Bioidentical Hormone Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Compounded Bioidentical Hormone Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Compounded Bioidentical Hormone Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
